Cargando…
Potential value of pharmacological agents acting on toll-like receptor (TLR) 7 and/or TLR8 in COVID-19
The COVID-19 pandemic is an ongoing global pandemic of coronavirus disease 2019 as an atypical type of viral pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Many potential pharmacotherapies are currently being investigated against this disease. This article points t...
Autores principales: | Khalifa, Amani E., Ghoneim, Asser I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562070/ https://www.ncbi.nlm.nih.gov/pubmed/34870161 http://dx.doi.org/10.1016/j.crphar.2021.100068 |
Ejemplares similares
-
Contrasted evolutionary histories of two Toll-like receptors (Tlr4 and Tlr7) in wild rodents (MURINAE)
por: Fornůsková, Alena, et al.
Publicado: (2013) -
Human Toll-like Receptor 8 (TLR8) Is an Important Sensor of Pyogenic Bacteria, and Is Attenuated by Cell Surface TLR Signaling
por: Moen, Siv H., et al.
Publicado: (2019) -
Expression of toll like receptor 8 (TLR8) in specific groups of mouse hippocampal interneurons
por: Seizer, Lennart, et al.
Publicado: (2022) -
Toll-Like Receptor (TLR2 and TLR4) Polymorphisms and Chronic Obstructive Pulmonary Disease
por: Budulac, Simona E., et al.
Publicado: (2012) -
Expression of Toll-Like Receptors (TLR2 and TLR4) in the Eyes of Mice with Disseminated Acanthamoebiasis
por: Kot, Karolina, et al.
Publicado: (2019)